15 completed, 8 terminated, 3 recruiting, 2 unknown. 30 Phase 1, 17 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 30 | Completed 15, Terminated 8, Recruiting 3, Unknown 2, Not yet recruiting 1, Withdrawn 1 |
| Phase 2 | 17 | Completed 8, Terminated 5, Recruiting 2, Not yet recruiting 1, Withdrawn 1 |
Follow Fanconi Anemia: new trials by email Literature Review of Fanconi Anemia trials Research Report on Fanconi Anemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Prenatal Transplantation for Fetuses With Fanconi Anemia IUHSCT for FA-affected fetuses - Fanconi Anemia, Anemia, Hypoplastic, Congenital | Phase 1 / Phase 2 | Not yet recruiting | Agnieszka Czechowicz | 12 | 2028-01-01 | 2026-06-16 |
| Safety and Tolerability of Metformin and Naproxen for Cancer Prevention in Fanconi Anemia Metformin, Naproxen Sodium - Fanconi Anemia, Head and Neck Cancer | Phase 1 | Recruiting | Rockefeller University | 80 | 2026-10-14 | 2026-10-28 |
| Afatinib in Patients With Fanconi Anemia (FA) and Advanced Head and Neck Squamous Cell Carcinoma (HNSCC) Afatinib - Fanconi Anemia, Head and Neck Squamous Cell Carcinoma | Phase 1 / Phase 2 | Recruiting | Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | 25 | 2024-11-08 | 2026-05-27 |
| A Dose Escalation Study of FP-045 in Patients With Fanconi Anemia FP-045 - Fanconi Anemia | Phase 1 / Phase 2 | Withdrawn | Foresee Pharmaceuticals Co., Ltd. | 2023-06-30 | 2025-03-06 | |
| Depleted Donor Stem Cell Transplant in Children and Adults With Fanconi Anemia After Being Conditioned With a Regimen Containing Briquilimab JSP191, CliniMACS Prodigy System, Depleted Stem Cell Transplant - Fanconi Anemia | Phase 1 / Phase 2 | Recruiting | Porteus, Matthew, MD | 18 | 2021-12-07 | 2026-01-27 |
| Mobilization and Collection of Peripheral Blood Stem Cells in Patients With Fanconi Anemia Using G-CSF and Plerixafor G-CSF, Plerixafor - Fanconi Anemia | Phase 1 / Phase 2 | Completed | Assistance Publique - Hôpitaux de Paris | 4 | 2017-02-10 | 2025-09-11 |
| Long Term Follow-up Study for Patients Enrolled on the BP-004 Clinical Study Rimiducid, rivogenlecleucel - Acute Lymphoblastic Leukemia, Leukemia, Acute Myeloid (AML), Child | Phase 1 / Phase 2 | Terminated | Bellicum Pharmaceuticals | 187 | 2017-01-01 | 2023-09-26 |
| A Phase 1/2 Trial of SRA737 in Subjects With Advanced Cancer SRA737 - Advanced Solid Tumors or Non-Hodgkin's Lymphoma (NHL) | Phase 1 / Phase 2 | Completed | Sierra Oncology LLC - a GSK company | 107 | 2016-07-01 | 2023-06-18 |
| A Phase 1/2 Trial SRA737 in Combination With Gemcitabine and Cisplatin or Gemcitabine Alone in Advanced Cancer Subjects SRA737, gemcitabine, cisplatin, SRA737, gemcitabine - Advanced Solid Tumors | Phase 1 / Phase 2 | Completed | Sierra Oncology LLC - a GSK company | 153 | 2016-07-01 | 2023-06-22 |
| Lentiviral-mediated Gene Therapy of Fanconi Anemia Patients Subtype A IV administration of Genetically Engineered Hematopoietic Stem/Progenitors Cells (HSPCs), Genetically Engineered Hematopoietic Stem/Progenitor Cells, Laboratory Biomarker Analysis - Fanconi Anemia | Phase 1 / Phase 2 | Completed | Hospital Infantil Universitario Niño Jesús, Madrid, Spain | 9 | 2016-01-07 | 2024-03-21 |
| Safety Study of Gene Modified Donor T Cell Infusion After Stem Cell Transplant for Non-Malignant Diseases BPX-501 and Rimiducid - Primary Immune Deficiency Disorders, Hemophagocytic Lymphohistiocytosis | Phase 1 | Terminated | Bellicum Pharmaceuticals | 1 | 2015-02-01 | 2024-03-25 |
| Safety Study of Gene Modified Donor T-cells Following TCRαβ+ Depleted Stem Cell Transplant BPX-501 T cells, Rimiducid - Acute Lymphoblastic Leukemia, Leukemia, Acute Myeloid (AML), Child | Phase 1 / Phase 2 | Terminated | Bellicum Pharmaceuticals | 187 | 2014-04-01 | 2023-09-29 |
| Bone Marrow Transplant With Abatacept for Non-Malignant Diseases Abatacept - Hurler Syndrome, Fanconi Anemia | Phase 1 | Completed | Emory University | 10 | 2014-01-01 | 2019-12-26 |
| Quercetin in Children With Fanconi Anemia; a Pilot Study Quercetin (dietary supplement) - Fanconi Anemia | Phase 1 | Completed | Children's Hospital Medical Center, Cincinnati | 30 | 2012-07-01 | 2024-01-18 |
| Gene Therapy for Fanconi Anemia Bone Marrow Aspiration, Filgrastim, Genetically Engineered Hematopoietic Stem Progenitor Cells - Fanconi Anemia | Phase 1 | Terminated | Fred Hutchinson Cancer Center | 3 | 2012-02-22 | 2024-05-17 |
| Safety and Efficacy Trial of Danazol in Patients With Fanconi Anemia or Dyskeratosis Congenita danazol - Fanconi Anemia, Dyskeratosis Congenita | Phase 1 / Phase 2 | Terminated | Boston Children's Hospital | 5 | 2009-11-01 | 2019-02-19 |
| Mobilization and Collection of Peripheral Blood Stem Cells in Patients With Fanconi Anemia Using G-CSF and AMD3100 AMD3100, AmCell CliniMACs - Fanconi Anemia | Phase 1 / Phase 2 | Completed | Children's Hospital Medical Center, Cincinnati | 1 | 2007-05-01 | 2020-10-30 |
| Bone Marrow Cell Gene Transfer in Individuals With Fanconi Anemia Retrovirus Construct - Fanconi Anemia | Phase 1 | Completed | Boston Children's Hospital | 3 | 2004-08-01 | 2017-06-23 |
| Oxandrolone for the Treatment of Bone Marrow Aplasia in Fanconi Anemia Oxandrolone - Fanconi Anemia | Phase 1 | Completed | Children's Hospital Medical Center, Cincinnati | 10 | 2004-07-01 | 2011-07-15 |
| Stem Cell Transplantation for Fanconi Anemia Hematopoietic Stem Cell Transplant, Thymic Shielding During Radiation, Total Body Irradiation - Fanconi Anemia | Phase 1 / Phase 2 | Terminated | Masonic Cancer Center, University of Minnesota | 16 | 2004-03-01 | 2019-08-26 |
Showing 20 of 30. Sign in to see all of them.
Anemia, Aplastic (6) · Anemia, Diamond-Blackfan (5) · Anemia, Sickle Cell (4) · Anemia (3) · Dyskeratosis Congenita (3) · Hemoglobinopathies (3) · Leukemia (3) · Lymphoma, Non-Hodgkin (3) · Primary Immunodeficiency Diseases (3) · Thalassemia (3) · Bone Marrow Failure Disorders (2) · Congenital Bone Marrow Failure Syndromes (2) · Cytopenia (2) · Granulomatous Disease, Chronic (2)
Bone Marrow Diseases (30) · Hemic and Lymphatic Diseases (30) · Nutritional and Metabolic Diseases (30) · Anemia, Hypoplastic, Congenital (29) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (29) · DNA Repair-Deficiency Disorders (29) · Genetic Diseases, Inborn (29) · Metabolic Diseases (29) · Bone Marrow Failure Disorders (28) · Congenital Bone Marrow Failure Syndromes (28) · Hematologic Diseases (28) · Anemia (27) · Anemia, Aplastic (24) · Neoplasms (7) · Neoplasms by Histologic Type (7)
Cyclophosphamide (5) · Filgrastim (5) · fludarabine (5) · Cyclosporine (4) · Granulocyte Colony-Stimulating Factor (4) · fludarabine phosphate (4) · plerixafor (4) · Antilymphocyte Serum (3) · Methylprednisolone (3) · AP 1903 reagent (2) · Alemtuzumab (2) · Mycophenolic Acid (2) · Peripheral Blood Stem Cell Transplantation (2) · Radiotherapy (2) · SRA737 (2)
Bellicum Pharmaceuticals (3) · Children's Hospital Medical Center, Cincinnati (3) · Fred Hutchinson Cancer Center (3) · Baylor College of Medicine (2) · Boston Children's Hospital (2) · Masonic Cancer Center, University of Minnesota (2) · Sierra Oncology LLC - a GSK company (2) · University of Minnesota (2) · Agnieszka Czechowicz (1) · Assistance Publique - Hôpitaux de Paris (1) · Dana-Farber Cancer Institute (1) · Emory University (1) · Foresee Pharmaceuticals Co., Ltd. (1) · Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau (1) · Hospital Infantil Universitario Niño Jesús, Madrid, Spain (1)
United States (21) · Spain (3) · United Kingdom (3) · Italy (2) · Brazil (1) · France (1) · Germany (1)
Hans-Peter Kiem (2) · John E. Wagner, Jr. (2) · Agata Smogorzewska, MD, PhD (1) · Colin A Sieff, MB.BCh (1) · Franklin O Smith, M.D. (1) · Franklin O. Smith, MD (1) · Hans-Peter Kiem, MD (1) · John T Horan, MD (1) · Juan A Bueren (1) · Malcolm Brenner, M.B., Ph.D., (1) · Malcolm Brenner, MB, PhD (1) · Margaret L. MacMillan, MD (1)
PMID 25824692, PMID 31501599, PMID 34665631, PMID 34751952, PMID 36378548, PMID 37120671, PMID 37142543, PMID 39642902, PMID 39820512, PMID 40696207, PMID 40859225
R01HL081499 (2), 2014 (1), P30CA015704 (1)